SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-139074
Filing Date
2018-04-27
Accepted
2018-04-27 16:34:55
Documents
6
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEFA14A d437483ddefa14a.htm DEFA14A 40923
2 GRAPHIC g437483noticepg2b.jpg GRAPHIC 2536
3 GRAPHIC g437483snap1.jpg GRAPHIC 3206
4 GRAPHIC g437483snap2.jpg GRAPHIC 3152
5 GRAPHIC g437483snap3.jpg GRAPHIC 3212
6 GRAPHIC g437483snap4.jpg GRAPHIC 3193
  Complete submission text file 0001193125-18-139074.txt   63758
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35347 | Film No.: 18784551
SIC: 2834 Pharmaceutical Preparations